Literature DB >> 17850060

4-[omega-[4-arylpiperazin-1-yl]alkoxy]phenyl)imidazo[1,2-a]pyridine derivatives: fluorescent high-affinity dopamine D3 receptor ligands as potential probes for receptor visualization.

Marcello Leopoldo1, Enza Lacivita, Elena Passafiume, Marialessandra Contino, Nicola A Colabufo, Francesco Berardi, Roberto Perrone.   

Abstract

Sixteen long-chain arylpiperazines bearing the fluorescent moiety 2-phenylimidazo[1,2-a]pyridine were synthesized as fluorescent dopamine D3 receptors ligands (385 nM < Ki < 0.72 nM). The most potent D3 compounds 15a and 19a (Ki = 1.6 and 0.72 nM, respectively) showed good Stokes shift and high quantum yield in ethanol (Phi = 0.74 and 0.66, respectively). In the first attempt, 15a was unable to visualize D3 receptors expressed in CHO cells by epifluorescence microscopy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17850060     DOI: 10.1021/jm070721+

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

Review 1.  Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors.

Authors:  Rajashri Sridharan; Jeffrey Zuber; Sara M Connelly; Elizabeth Mathew; Mark E Dumont
Journal:  Biochim Biophys Acta       Date:  2013-09-18

2.  Synthesis and characterization of selective dopamine D₂ receptor ligands using aripiprazole as the lead compound.

Authors:  Suwanna Vangveravong; Zhanbin Zhang; Michelle Taylor; Melissa Bearden; Jinbin Xu; Jinquan Cui; Wei Wang; Robert R Luedtke; Robert H Mach
Journal:  Bioorg Med Chem       Date:  2011-04-16       Impact factor: 3.641

3.  Differently fluorescence-labelled dibenzodiazepinone-type muscarinic acetylcholine receptor ligands with high M2R affinity.

Authors:  Corinna G Gruber; Andrea Pegoli; Christoph Müller; Lukas Grätz; Xueke She; Max Keller
Journal:  RSC Med Chem       Date:  2020-06-08

4.  Synthesis and cytotoxic activity evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.

Authors:  Hong Chen; Xue Liang; Fang Xu; Bingbing Xu; Xuelan He; Biyun Huang; Mu Yuan
Journal:  Molecules       Date:  2014-08-12       Impact factor: 4.411

5.  Synthesis, bioactivity, and molecular docking of novel arylpiperazine derivatives as potential AR antagonists.

Authors:  Yueheng Qi; Hong Chen; Shijin Chen; Jianliang Shen; Jingguo Li
Journal:  Front Chem       Date:  2022-08-15       Impact factor: 5.545

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.